These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11262079)

  • 41. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.
    Matsubara T; Moskowitz MA; Byun B
    Br J Pharmacol; 1991 Sep; 104(1):3-4. PubMed ID: 1664765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
    J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
    Bou J; Domènech T; Puig J; Heredia A; Gras J; Fernández-Forner D; Beleta J; Palacios JM
    Eur J Pharmacol; 2000 Dec; 410(1):33-41. PubMed ID: 11134654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 46. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
    Goadsby PJ; Hoskin KL
    Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.
    Cumberbatch MJ; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1998 Nov; 362(1):43-6. PubMed ID: 9865528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
    Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists.
    Slassi A; Edwards L; O'Brien A; Meng CQ; Xin T; Seto C; Lee DK; MacLean N; Hynd D; Chen C; Wang H; Kamboj R; Rakhit S
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1707-9. PubMed ID: 10937729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
    O'Neill MF; Sanger GJ
    Eur J Pharmacol; 1999 Apr; 370(2):85-92. PubMed ID: 10323255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
    van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
    Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles.
    van Niel MB; Collins I; Beer MS; Broughton HB; Cheng SK; Goodacre SC; Heald A; Locker KL; MacLeod AM; Morrison D; Moyes CR; O'Connor D; Pike A; Rowley M; Russell MG; Sohal B; Stanton JA; Thomas S; Verrier H; Watt AP; Castro JL
    J Med Chem; 1999 Jun; 42(12):2087-104. PubMed ID: 10377215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-HT(1B/D) receptor agonist, SKF99101H, induces locomotor hyperactivity in the guinea pig.
    O'Neill MF; Dobson DR; Sanger GJ
    Eur J Pharmacol; 2000 Jun; 399(1):49-55. PubMed ID: 10876022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.
    Shepherd SL; Williamson DJ; Beer MS; Hill RG; Hargreaves RJ
    Neuropharmacology; 1997; 36(4-5):525-33. PubMed ID: 9225277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate.
    Lambert GA; Boers PM; Hoskin KL; Donaldson C; Zagami AS
    Brain Res; 2002 Oct; 953(1-2):181-8. PubMed ID: 12384251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin in trigeminal ganglia of female rodents: relevance to menstrual migraine.
    Berman NE; Puri V; Chandrala S; Puri S; Macgregor R; Liverman CS; Klein RM
    Headache; 2006 Sep; 46(8):1230-45. PubMed ID: 16942467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.
    Street LJ; Baker R; Davey WB; Guiblin AR; Jelley RA; Reeve AJ; Routledge H; Sternfeld F; Watt AP; Beer MS
    J Med Chem; 1995 May; 38(10):1799-810. PubMed ID: 7752204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.